Lixisenatide
Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
Sanofi · Phase 2 · Terminated · Enrollment 2
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| lixisenatide | n/r | n/r | n/r | n/r |
| metformin | n/r | n/r | n/r | n/r |
Not shown
- lixisenatide: endpoint not reported
- metformin: endpoint not reported